Reporte zur Charge 032L2U9

Symptomtext

redness (vaccination site); Arm pain; Swollen arm; Swollen neck; Dry Mouth; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L2U9) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE for Blood pressure abnormal. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) administered intramuscularly, the reporter did not provide any causality assessments.